$2.79
0.145.28%
Ult. Agg.: Nov 6, 6:40 PM
The average analyst price target for ARS Pharmaceuticals is $24, 763.3% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $17 to $40. The latest change came on Nov 6, 2026, when Cantor Fitzgerald lowered its price target on ARS Pharmaceuticals from $30 to $20 and kept an Overweight rating.
Price Target Range — 9 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months